TrialCells2022

Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics.

Konstantinos I Avgerinos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.